MRVI

7.0152.43%
JA

John A. DeFord

Independent Director

Dr. John A. DeFord, Ph.D., is Member of Supervisory Board of Koninklijke Philips N.V. from May 8, 2026. Dr. DeFord served as Independent Director at Globus Medical, Inc. since September 2023 until March 23, 2026. He served as Director at GeniPhys, Inc. He serves as Independent Director at Maravai LifeSciences Holdings, Inc. since July 20, 2023. He is a Director at Enable Injections, Inc. from July 29, 2022. He served as Director of Blue Spark Technologies, Inc. since April 13, 2022 until April 2026. He serves as Independent Director at Nordson Corporation since November 23, 2020. He serves as Executive Vice President of Research and Development and served as Chief Technology Officer until May 2021 at Becton Dickinson and Co. He had been Executive Vice President and Chief Technology Officer at Becton Dickinson and Co., since June 1, 2018, until he retired from Becton Dickinson in May 2021. He served as Senior Vice President of Research and Development, Interventional Segment for BD (Becton, Dickinson and Company). He served as Senior Vice President for Science, Technology and Clinical Affairs at CR Bard Inc. since June 21, 2007. He served as Vice President of Science and Technology of CR Bard Inc. from January 20, 2004, to June 21, 2007. He joined C. R. Bard Inc. from Early-Stage Partners, a venture capital fund based in Cleveland, OH, where he served as Managing Director, responsible for life sciences investments. He spent with Cook Inc., where he served as the President and Chief Executive Officer since 2001. He had been an Independent Director of NuVasive, Inc. since February 26, 2018, until 2023. He was oversight of Bard's research and new product development program. He served as the Chief Executive Officer of Cook Group Inc. He conducted extensive research and authored numerous scientific and business publications throughout his career. He served as a Director of AxioMed Spine Corporation. He received a B.S. and M.S. degree in Electrical Engineering and a PhD in Electrical and Biomedical Engineering all from Purdue University. He has been the Chairman, Chief Executive Officer and President of Samothrace Medical Innovations, Inc., a medical technology company, since coming out of retirement in March 2022. He joined Becton Dickinson in December 2017. He was Managing Director of Early-Stage Partners, a venture capital fund. He was President and Chief Executive Officer of Cook Incorporated, medical device manufacturer.

Positions